A Study to Evaluate the Pharmacokinetics of Adalimumab in Combination With Methotrexate for the Treatment of Patients With Ulcerative Colitis
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Nov 2017
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics
- 09 Nov 2017 Planned End Date changed from 1 Nov 2017 to 31 Jul 2018.
- 09 Nov 2017 Planned primary completion date changed from 1 May 2017 to 31 Jan 2018.
- 09 Nov 2017 Status changed from recruiting to active, no longer recruiting.